BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38239856)

  • 1. Multimodal Management of Colorectal Liver Metastases: State of the Art.
    Filoni E; Musci V; Di Rito A; Inchingolo R; Memeo R; Mannavola F
    Oncol Rev; 2023; 17():11799. PubMed ID: 38239856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal treatment strategies for colorectal liver metastases.
    Birrer DL; Tschuor C; Reiner C; Fritsch R; Pfammatter T; Garcia Schüler H; Pavic M; De Oliveira M; Petrowsky H; Dutkowski P; Oberkofler C; Clavien PA
    Swiss Med Wkly; 2021 Feb; 151():w20390. PubMed ID: 33631027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thermal ablation in the management of colorectal liver metastasis.
    Takahashi H; Berber E
    Hepatobiliary Surg Nutr; 2020 Feb; 9(1):49-58. PubMed ID: 32140478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
    Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
    HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis.
    Nieuwenhuizen S; Dijkstra M; Puijk RS; Geboers B; Ruarus AH; Schouten EA; Nielsen K; de Vries JJJ; Bruynzeel AME; Scheffer HJ; van den Tol MP; Haasbeek CJA; Meijerink MR
    Curr Oncol Rep; 2022 Jun; 24(6):793-808. PubMed ID: 35298796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
    van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
    Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of single pulmonary metastases from colorectal cancer: State of the art.
    Chiappetta M; Salvatore L; Congedo MT; Bensi M; De Luca V; Petracca Ciavarella L; Camarda F; Evangelista J; Valentini V; Tortora G; Margaritora S; Lococo F
    World J Gastrointest Oncol; 2022 Apr; 14(4):820-832. PubMed ID: 35582100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
    Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer.
    Kallini JR; Gabr A; Abouchaleh N; Ali R; Riaz A; Lewandowski RJ; Salem R
    Cancer J; 2016; 22(6):373-380. PubMed ID: 27870679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal liver metastases: Current management and future perspectives.
    Martin J; Petrillo A; Smyth EC; Shaida N; Khwaja S; Cheow HK; Duckworth A; Heister P; Praseedom R; Jah A; Balakrishnan A; Harper S; Liau S; Kosmoliaptsis V; Huguet E
    World J Clin Oncol; 2020 Oct; 11(10):761-808. PubMed ID: 33200074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.
    Mauri G; Monfardini L; Garnero A; Zampino MG; Orsi F; Della Vigna P; Bonomo G; Varano GM; Busso M; Gazzera C; Fonio P; Veltri A; Calandri M
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal liver metastases: An update on multidisciplinary approach.
    Chow FC; Chok KS
    World J Hepatol; 2019 Feb; 11(2):150-172. PubMed ID: 30820266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases.
    Rhaiem R; Rached L; Tashkandi A; Bouché O; Kianmanesh R
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Liver Metastases: Multimodal Therapy.
    Aykut B; Lidsky ME
    Surg Oncol Clin N Am; 2023 Jan; 32(1):119-141. PubMed ID: 36410912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.
    Nieuwenhuizen S; Puijk RS; van den Bemd B; Aldrighetti L; Arntz M; van den Boezem PB; Bruynzeel AME; Burgmans MC; de Cobelli F; Coolsen MME; Dejong CHC; Derks S; Diederik A; van Duijvendijk P; Eker HH; Engelsman AF; Erdmann JI; Fütterer JJ; Geboers B; Groot G; Haasbeek CJA; Janssen JJ; de Jong KP; Kater GM; Kazemier G; Kruimer JWH; Leclercq WKG; van der Leij C; Manusama ER; Meier MAJ; van der Meijs BB; Melenhorst MCAM; Nielsen K; Nijkamp MW; Potters FH; Prevoo W; Rietema FJ; Ruarus AH; Ruiter SJS; Schouten EAC; Serafino GP; Sietses C; Swijnenburg RJ; Timmer FEF; Versteeg KS; Vink T; de Vries JJJ; de Wilt JHW; Zonderhuis BM; Scheffer HJ; van den Tol PMP; Meijerink MR
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Added Diagnostic Value of Transcatheter CT Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan.
    van der Lei S; Opperman J; Dijkstra M; Kors N; Boon R; van den Bemd BAT; Timmer FEF; Nota IMGC; van den Bergh JE; de Vries JJJ; Scheffer HJ; Geboers B; Neuss T; Schouten E; Lissenberg-Witte BI; Puijk RS; Meijerink MR
    Cardiovasc Intervent Radiol; 2023 Sep; 46(9):1257-1266. PubMed ID: 37491521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection for colorectal cancer metastases.
    Gallinger S; Biagi JJ; Fletcher GG; Nhan C; Ruo L; McLeod RS
    Curr Oncol; 2013 Jun; 20(3):e255-65. PubMed ID: 23737695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.
    Joharatnam-Hogan N; Wilson W; Shiu KK; Fusai GK; Davidson B; Hochhauser D; Bridgewater J; Khan K
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.